Skip to main content
Clinical Trials/NCT00882271
NCT00882271
Completed
Not Applicable

Efficacy of Acupuncture to Improve Symptoms and Functionality for People With Fibromyalgia

Southern California University of Health Sciences0 sites50 target enrollmentJanuary 2008
ConditionsFibromyalgia

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Fibromyalgia
Sponsor
Southern California University of Health Sciences
Enrollment
50
Primary Endpoint
Beck Depression Inventory
Status
Completed
Last Updated
14 years ago

Overview

Brief Summary

The acupuncture treatment in this study is particularly aimed at reducing the pain and other negative health events such as emotional trauma and disability associated with Fibromyalgia, while improving the quality of life and promoting general health.

Detailed Description

It is hypothesized that acupuncture treatment will be effective in reducing pain and improving lower body strength and overall functionality more than the sham acupuncture treatment in people with Fibromyalgia (FM). The purpose of this study is to compare the efficacy of acupuncture with simulated acupuncture in patients with FM using a randomized controlled design. More specifically, the objectives of this study are to determine if acupuncture can (1) reduce pain, (2) improve lower body strength, and (3) improve overall functionality.

Registry
clinicaltrials.gov
Start Date
January 2008
End Date
November 2011
Last Updated
14 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Sivarama Vinjamury

Fibromyalgia Acupuncture Study

Southern California University of Health Sciences

Eligibility Criteria

Inclusion Criteria

  • Participants must be 18 years or older and can be of either sex.
  • A confirmed diagnosis of FM (pain for more than three months) will be required to participate in the study. If they do not have a diagnosis the study clinician or research assistant will examine them and determine their eligibility.
  • All participants must be willing to provide a written informed consent prior to participation and should not have undergone acupuncture treatment in the past.

Exclusion Criteria

  • Acupuncture treatment in the past five years.
  • Unwilling to sign informed consent.
  • Less than a score of 40 on the Fibromyalgia Impact Questionnaire,
  • Involvement in any litigation currently or in the past,
  • Simultaneous infection with HIV/Hepatitis B virus.
  • Severe depression (Beck depression score \>21),
  • History of substance abuse or dependence within the past year, excluding nicotine and caffeine.
  • Serious or unstable cardiovascular, hepatic, renal, respiratory, or hematologic illness, symptomatic peripheral vascular disease, or other medical conditions (including unstable hypertension, hypo or hyperthyroidism, or psychological conditions that in the opinion of the investigators would compromise participation or be likely to lead to an adverse response, including injuries or hospitalization, during the course of the study. We will get the information from the health/activity questionnaire.
  • Have any DSM-IV Axis (major depression, addiction, anxiety) disorder which, in the judgment of the investigators, would interfere with compliance with the study protocol.

Outcomes

Primary Outcomes

Beck Depression Inventory

Time Frame: Baseline and end of 5th, 10th treatments and end of 1, 2, 3, 4, 5, and 6 months

Health/Activity Questionnaire

Time Frame: Baseline

The Fibromyalgia Impact Questionnaire

Time Frame: Baseline and end of 5th, 10th treatments and end of 1, 2, 3, 4, 5, and 6 months

Multidimensional Pain Inventory

Time Frame: Baseline and end of 5th, 10th treatments and end of 1, 2, 3, 4, 5, and 6 months

Secondary Outcomes

  • 30-sec Chair Stand(Baseline and end of 5th, 10th treatments and end of 1, 2, 3, 4, 5, and 6 months)

Similar Trials